04:48 PM EDT, 07/22/2024 (MT Newswires) -- Medpace ( MEDP ) reported Q2 earnings late Monday of $2.75 per diluted share, up from $1.93 a year earlier.

Analysts polled by Capital IQ expected $2.53.

Revenue for the quarter ended June 30 was $528.1 million, up from $460.9 million a year earlier.

Analysts surveyed by Capital IQ expected $528.4 million.

The company said it expects 2024 EPS to be between $11.24 and $11.93 and revenue of $2.125 billion to $2.175 billion. Its previous guidance was for EPS of between $10.79 and $11.47 and revenue of between $2.15 billion and $2.20 billion.

Analysts polled by Capital IQ expect $11.24 and $2.17 billion, respectively.

The company's shares were falling about 13% in after-hours trading.

Price: 379.90, Change: -57.28, Percent Change: -13.10